Pioneering Brain Health Research

Geneva advances brain health research to address one of military medicine’s most urgent challenges: traumatic brain injury (TBI). From rapid diagnostics to long-term recovery, our work spans the full continuum of care—advancing early intervention, advanced therapies, and cognitive restoration to improve outcomes, readiness, and quality of life for service members.

Why TBI Research Matters

TBI research is vital to protecting force health and sustaining military readiness:

• • • High Prevalence: TBIs remain a leading cause of military-related injuries.
    • Blast Exposure Risks: Repetitive trauma and blast exposure increase the likelihood of chronic brain conditions.
    • Critical Intervention: Early intervention and advanced therapies reduce long-term impacts, accelerating recovery and enhancing survivorship.

The Geneva Advantage

With deep DoD expertise and agile contracting infrastructure, Geneva accelerates brain health research from discovery to deployment—delivering mission-ready solutions for the warfighter.

• • • Collaborative Expertise: Engagement with leading military research facilities, including Brooke Army Medical Center and Walter Reed Army Institute of Research, strengthens innovation.
    • Diagnostic Innovation: Development of biomarker tools and advanced diagnostics enables faster, more accurate identification of brain injuries.
    • Neurotechnology Leadership: Pioneering use of virtual reality, telehealth applications, and other advanced tools improves recovery and long-term outcomes.

By integrating clinical expertise with cutting-edge technology, Geneva transforms discovery into tangible solutions that improve brain health and readiness.